Quentin James Sattentau PhD

Quentin James Sattentau completed his BSc in microbiology from The University of Bristol, UK (1980), and PhD in virology and immunology of HSV-1 infection from The University of London, UK (1985). He studied Postdoctoral studies on the interaction of HIV-1 with CD4 with Peter Beverley and Robin Weiss at University College London UK, and Richard Axel at the HHMI, Columbia University NY. In 1992 he took up a tenured post as CNRS Director of Research (DR2) at the Centre immunology in Marseille France. where he worked on HIV-1 envelope glycoprotein structure, function, and interaction with neutralizing antibodies. After a sabbatical in Geoff Smith’s lab at the Dunn School of Pathology Oxford in 1998, he took up the post of Senior Lecturer at Imperial College in 1999. He joined Oxford University as a Professor of Immunology. Current research interests are in two broad areas: i) designing strategies to elicit neutralizing anti-protein and anti-glycan antibodies as vaccination strategies to control HIV-1 and cancer; ii) understanding how phagocytes recognize and efferocytosis dying cells via loss of 'don't eat-me' signals.